Cell-sequencing technology investigates the genetic material of cells so that it can distinguish molecular differences in cell populations. This is important for understanding disease development and complex tissues like tumors, since it helps track tumor growth, understand the tumor microenvironment, and find new mutational targets for chemotherapy. In this last decade, cell-sequencing technologies have undergone rapid development, including single-cell sequencing, which allows gene expression to be analyzed at the resolution of individual cells. 

Conventional bulk sequencing averages gene expression across heterogeneous cell populations. It is cost-effective and enables large-scale analysis, which is useful for comparing general conditions, discovering major biomarkers, and revealing population-level trends. However, this loses meaningful cellular heterogeneity. Single-cell RNA sequencing (scRNA-seq), on the other hand, profiles transcriptomes (all the messenger RNA molecules expressed from the genes of an organism) at single-cell resolution; hence, it allows nuanced insights into cell types, states, and functions (Zhang et al., 2024; Fang et al., 2024). 

These technologies have also oriented global initiatives such as the Human Cell Atlas, and they have large implications for understanding human biology and disease pathogenesis. In particular, several projects related to the central nervous system (CNS), like the Brain Cell Atlas, have already shown how large-scale single-cell transcriptomic data can map cellular heterogeneity across brain regions and inform research into neurological disorders (Chen et al., 2024).  

The single-cell transcriptomics workflow begins with the isolation of either single cells or nuclei from a sample of interest. Active genes in the cell are transcribed into RNA molecules, which then get trapped upon lysing into the cell membrane. This is followed by reverse transcription of RNA into cDNA, where the single-stranded RNA is used to generate its complementary DNA strand, followed by library preparation, which makes the raw DNA “library” of fragments ready for high-throughput sequencing. 

 

Modern protocols such as microfluidic droplet platforms and fluorescence-activated cell sorting can capture and process thousands to millions of cells per experiment (Zhang et al., 2024). The analytical pipelines then proceed to cluster cells according to their expression profiles into classes and subtypes, infer lineage trajectories, and deduce cell-to-cell communication networks (Zhang et al., 2024). Challenges like technical noise and batch effects across datasets still exist, causing ongoing research to focus on algorithmic improvement and multimodal integration (Fang et al., 2024). 

The techniques of spatial transcriptomics and its derivatives extend scRNA-seq while retaining the spatial context of samples. This, therefore, allows researchers to map where cells reside within intact tissues. Spatial methods do not dissociate the tissue, which can disrupt cell interactions, and they therefore provide interesting insights into how tissue architecture influences molecular programs (Zhang et al., 2024). 

The Human Cell Atlas (HCA) is an ambitious international collaboration to create a complete reference to all human cell types across all tissues and stages of life. The HCA strives to standardize cellular nomenclature and build openly accessible data resources for the scientific community. These atlases will serve as foundational ‘part lists’ of biology, facilitating tissue comparisons and disease mechanism interpretation. 

A major breakthrough in CNS atlasing was the Brain Cell Atlas, an integrated resource of over 26.3 million cells and nuclei collated from 70 human and 103 mouse studies covering 14 major brain regions (Chen et al., 2024). These data were then further harmonized using machine-learning-based annotation pipelines to generate a consensus map of cell types that was able to reveal both common and region-specific cell populations (Chen et al., 2024). The atlas, for example, identified putative adult neural progenitor cells and novel microglia subtypes characterized by high PCDH9 expression, indicative of subtle cellular diversity that would be quite challenging to detect in single studies (Chen et al., 2024). 

Beyond describing neuron and glial diversity, integrated atlases reveal regional specialization of non-neuronal populations, and even potential cellular signatures associated with neurological disease, laying out a framework for understanding brain complexity in both health and pathology (Chen et al., 2024). These resources are often linked to interactive portals and visualization tools, enabling continuous discovery and hypothesis generation. 

Single-cell sequencing has rapidly become indispensable in CNS disease research. Recent reviews have elaborated on how scRNA-seq explicates disease mechanisms through characterizing cellular heterogeneity, mapping pathological cell states, and identifying novel biomarkers (Zhang et al., 2024). However, perhaps most importantly in CNS disease research, scRNA-seq helps identify potential therapeutic targets across several CNS disorders like Alzheimer’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and acute injuries, like strokes or trauma (Fang et al., 2024). It provides great insight into how specific cell types change in disease contexts, allowing researchers to better understand the pathophysiological details that were previously inaccessible through bulk sequencing methods. 

The scRNA-seq also captures microglial states associated with disease or reactive astrocyte phenotypes correlating with neuroinflammatory processes. Spatially resolved gene expression further contextualizes these states within tissue architecture, capturing how cells interact in disease microenvironments, which is the interpretation of tissue pathology and the indispensable advantage for developing targeted interventions (Zhang et al., 2024). Moreover, computational innovations such as self-supervised learning approaches enable the integration of multi-dataset scRNA-seq data across species and disease states, enhancing reference quality and enabling more accurate mapping of cellular phenotypes (Fang et al., 2024). These integrative strategies help bridge interstudy variability and help support the large-scale comparisons essential for robust CNS disease modeling.

 
Despite significant advances, there are still several remaining challenges when it comes to single-cell atlas construction and their further application. Integrating heterogeneous datasets generated by different technologies and platforms requires advanced computational frameworks to handle batch effects while maintaining biologically meaningful distinctions. While incredibly powerful, spatial transcriptomics is still constrained by resolution and throughputs, and it often requires complementary scRNA-seq for complete transcriptomic and spatial insights. 

In CNS research, scalability to clinical sample sizes and diversity remain ongoing challenges, as well as harmonizing atlases across populations to ensure representative baselines in health and disease. Integrating multi-omics (epigenomics, proteomics) with transcriptomics promises deeper functional insights at a higher cost in computational complexity and data management demands. 
Emerging trends, including machine learning-assisted cell type annotation and multimodal data integration, will continue streamlining atlas refinement and interpretation. As data resources grow, the opportunity to translate atlas insights into precision medicine, such as identifying cell-type-specific therapeutic targets, approaches clinical feasibility.

Single-cell sequencing and atlas projects have changed everything about our understanding of the cellular composition and organization within human tissues. The Human Cell Atlas and the Brain Cell Atlas, which detail the contemporary topography of human cells, provide insights into cellular diversity and function. The atlases highlight the heterogeneous regions within the brain—the regions that change during pathology—thus serving to further stimulate research into the development, function, and pathological states of the brain. With continued development of technologies and analytic methods, creation of a full cellular atlas of the human body, and application thereof to biomedical research, remains an exciting possibility.

 

 

References 
Chen, X., Huang, Y., Huang, L., Huang, Z., Hao, Z.-Z., Xu, L., Xu, N., Li, Z., Mou, Y., Ye, M., You, R., Zhang, X., Liu, S., & Miao, Z. (2024). A brain cell atlas integrating single-cell transcriptomes across human brain regions. Nature Medicine, 30, 2679–2691. https://doi.org/10.1038/s41591-024-03150-z 
Fang , Y., Chen, J., Wang, H., Wang, S., Chang, M., Chen, Q., Shi, Q., Xian , L., Feng, M., Hu, B., & Wang, R. (2024). Integrating large-scale single-cell RNA sequencing in central nervous system disease using self-supervised contrastive learning. Communications Biology, 7. https://doi.org/10.1038/s42003-024-06813-2 
Zhang, Y., Li, T., Wang, G., & Ma, Y. (2024). Advancements in Single-Cell RNA Sequencing and Spatial Transcriptomics for Central Nervous System Disease. Cellular and Molecular Neurobiology, 44(1). https://doi.org/10.1007/s10571-024-01499-w